Brief: Equillium Inc - No Termination Fee Will Be Payable By Equillium Or Metacrine In Connection With The Termination Of The Merger Agreement
23/12/2022 21:15
Dec 23 (Reuters) - Equillium Inc EQ.O :
* EQUILLIUM INC - NO TERMINATION FEE WILL BE PAYABLE BY
EQUILLIUM
OR METACRINE IN CONNECTION WITH THE TERMINATION OF THE MERGER
AGREEMENT
Further company coverage: EQ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Equillium
See all newsBrief: Equillium Receives Australian Regulatory Clearance To Initiate First-In-Human Clinical Trial Of Eq504
Equillium Inc reports results for the quarter ended June 30 - Earnings Summary
Equillium Q2 post narrower net loss than expected; starts R&D initiatives
Equillium Inc expected to post a loss of 5 cents a share - Earnings Preview
Equillium Q1 net loss, profit miss analyst expectations